Italy: Brief Analysis Of The Proposed Changes To The Medical Device Directive 93/42/EEC

Last Updated: 23 April 2004
Article by Paola Sangiovanni

I. Medical Devices In Europe.

The EU Commission well understands the strategic importance of the medical device sector for Europe. Europe is the second-largest world market for medical devices, and about 8,000 types of devices are on the Community market. Additionally, the medical device sector, a highly innovative industry, is recognized as having a crucial impact on the quality of life of European patients, and impacts health care and health policy.

II. Legal Framework.

The basic legal framework on medical devices was laid out at the Community level during the 1990s. Three main directives have been enacted, in the following three fields:

  • Directive 90/385/EEC on active implantable medical devices;
  • Directive 93/42/EEC on medical devices ("MDD"); and
  • Directive 98/79/EC on in-vitro diagnostic.

Other Directives in this area include Directive 2000/70/EC, on medical devices incorporating stable derivates of human blood or human plasma, and Directive 2003/32/EC, on medical devices manufactured utilizing tissues of animal origin.

This article focuses on the MDD and on the changes that the Commission is considering adopting to improve the regulation of the medical device sector.

III. The Medical Device Directive.

The MDD is based on the principles of the so-called "New Approach" to technical harmonization and standards. In accordance with the New Approach, the MDD does not analytically specify the technical features that medical devices must possess, but instead defines the essential requirements that devices must meet in order to be marketed. This approach appeared more appropriate for the regulation of rapidly evolving technologies, whereas a detailed specification of the devices’ features would have necessitated a constant update of the applicable provisions to describe the ever-changing state of the art.

Under the MDD, devices are subdivided into four categories, depending on the potential risks that are associated with their use. Assessment procedures for Class I devices are based on the manufacturer’s evaluation only, while Class IIa, IIb and III devices may be marketed only after a specific, so-called "Notified Body" has inspected them.

IV. CE Marking.

Manufacturers of medical devices must perform a risk/benefit analysis regarding any device, reduce risks to the minimum, adopt any adequate safety measure, and fully inform users of any remaining risk. Compliance with this required conformity assessment results in the issue of the CE mark, without which marketing of the device is not allowed. Only devices intended for clinical investigations and custom-made devices can be placed on the market without any CE marking.

The CE mark serves the purpose of certifying compliance with the MDD and allows the device to freely circulate within the Community market. Under the "safeguard clause," however, Member States are entitled to take appropriate interim measures to prohibit or restrict the circulation of certain devices on the market when they may compromise the health or safety of patients or other users. As measures taken under the safeguard clause represent an exception to the free circulation of devices on the European Market, they are reviewed by the Commission, which assesses whether they are justified in a particular case.

V. Proposed Changes to the Medical Device Directive.

Pursuant to Section 11(4) of the MDD, the Commission conducted a review of the regulatory framework and released a Communication to the Council and the European Parliament on Medical Devices, which was published on July 2, 2003 ("Communication").

While the present overall functioning of the regulatory framework appears to be appropriate, the Communication highlights a number of areas where improvement is possible.

A. Conformity Assessment. The Commission identified shortcomings in the conformity assessment, particularly in relation to the role of Notified Bodies, and suggests reinforcing the obligations to provide clinical data to Notified Bodies, their evaluation of the manufacturer’s quality system and of the data presented, as well as the provisions requiring market surveillance. Further, reclassification mechanisms for devices should be used more effectively. Lastly, designation and monitoring of Notified Bodies should be improved and the creation of a Notified Bodies Operations Group is suggested.

B. Transparency and Trust. There is a lack of transparent and easily accessible data on medical devices with respect to certifications by the Notified Bodies, and the European Database for Medical Devices (EUDAMED) has not been satisfactorily implemented. The Communication suggests the creation of "EU Notified Body public assessment reports" including selected information on devices, that would take due account of the legitimate interests of manufacturers. Further, communication must be improved between Member States and Notified Bodies, as well as among the Notified Bodies themselves. Information should be provided on a regular basis to the Health and Policy Forum, representing consumers, patients and healthcare professionals, and EUDAMED should be fully implemented.

C. Market Surveillance. The Commission expressed concern over the varied levels of market surveillance, and cooperation by Member States on this matter is highly encouraged. Also suggested are mechanisms to ensure early-warning exchanges between authorities, as well as communication to all Member States of measures restricting circulation on the market of medical devicesre.

D. Cooperation between Commission and Member States. The existing cooperation between the Commission and Member States has proved to be insufficient in politically sensitive areas, in the case of safeguard clauses, and in standardization. The Commission proposes the establishment of a high-level group on medical devices composed of EU Member States, candidate countries and EFTA, which would not jeopardize any other body active in this field (such as the Medical Device Expert Group).

E. Enlargement. The Commission hopes that implementation of the MDD in accession countries will be carried out with sufficient human resources, and recommends that such countries join the various working groups and participate in workshops, consultations and mentoring.

F. The International Dimension. Many Mutual Recognition Agreements (MRAs) covering medical devices have been signed, but only the ones with Switzerland and Australia are operational. The entering into force of MRAs should in any event be based on the existence of strict guarantees. The Global Harmonization Task Force (GHTF) is an informal group of representatives from national medical device regulatory bodies in Europe, Asia Pacific and North America that has gained more and more importance, and Europe should continue to play a leading role in the activities of GHTF.

The Communication further identifies a number of areas for regulatory modification, the main aim of which is defining new rules for conformity assessment and classification (e.g., elimination of certain classification anomalies, validity of conformity assessment certificates and retention of product files, clarifications on clinical evaluations), and at aligning the rules set in the Active Implantable Medical Devices Directive with the MDD.

Other measures recommended by the Communication include:

    1. The launch of a study on the medical device sector;
    2. The creation of a High Level Group allowing consultation between the Commission and national authorities;
    3. Regular provision of information to the Health Policy Forum;
    4. The creation of a pilot project on EUDOMED; and
    5. That MDEG monitor the current practices in the areas of vigilance and standardization.

VI. Reactions and Conclusions.

The Communication generally has been well received by the industry. UEAPME (Union Europeenne de l’Artisanat et des Petites et Moyennes Enterprises) pointed out the importance of extending the reach of the MDD to third countries and of including custom-made medical devices in such efforts. In conclusion, it can be said that the Commission is not overlooking the importance of the medical device sector and is seriously taking measures to improve the safety of devices, as well as to ensure strict vigilance on the enforcement of the MDD’s rules and regulations.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Mondaq Advice Centre (MACs)
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.